Venture Search
Venture Search


Shiphrah Biomedical Inc.

Problem: Each year, over two million infants die before or during birth (stillbirth). Stillbirth (SB) is one of the most devastating complications of pregnancy and deeply impacts the mother, her partner, and family for many years. In high-income countr …


SensOR Medical Laboratories Ltd.

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/SensOR-Logo-v2-01-150×90.png SensOR Medical Laboratories Ltd. Description: [213] [214] [212] [215] Robert Brooks, Founder and CEO, robert@sensormedicallabs.com


Porphysome Foundry

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/Asset-2_2@4x-1-150×150.png Porphysome Foundry Description: [213] [214] [212] [215] Michael Valic, Project Manager, michael.valic@porphysome.ca


Polumiros Inc.

https://h2i.utoronto.ca/wp-content/uploads/formidable/14/logo-square-text2-150×150.png Polumiros Inc. Soror Sharifpoor, Kyle Battiston, CEO and Co-Founder, CSO and Co-Founder, ssharifpoor@polumiros.com, kbattiston@polumiros.com


Phoenox Pharma

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/PhoenoxPharma_logo_full@3x-1-150×150.png Phoenox Pharma Andrew Haller, PhD, CEO and Founder, andrew@phoenox.ca


Nutarniq Corp.

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/cropped-small-Nutarniq_Corp_blue_tagline_blue-c-150×150.jpg Nutanriq Corp Description: [213] [214] [212] [215] Dr. Evan Lewis, CEO, elewis@nutarniq.com


Notogen Inc.

Problem: Degenerative Disc Disease (DDD) is a large market opportunity, with high prevalence, healthcare cost burden and unmet need. DDD is a predominant contributor (~40%) to the genesis of spinal pain frequently manifesting as debilitating chronic lo …


MedStack

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/new-logo-square-150×150.jpg MedStack Balaji Gopalan, Simon Woodside, Jacob Jackson, Co-Founder and CEO, Co-Founder and CTO, Business Development Manager, https://www.linkedin.com/in/balgop …


MedEssist Ltd.

Problem: For patients, MedEssist addresses the critical issue of medication non-adherence which causes 125,000 deaths and 10% of hospitalizations each year in the US. Medication non-adherence also costs the pharmaceutical industry $637B worldwide in lo …


Magellan Biomedical Inc.

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/logo2_white_24bit_jpg_compass.ico_-150×150.jpg Magellan Biomedical Inc. Description: [213] [214] [212] [215] M. Ali Tavallaei, Graham Wright, Andrew Dueck, Trisha Roy, James Zhou, Josh Tol …


Luna Nanotech

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/Logo_v10-01-1-150×150.png Luna Nanotech Inc. Description: [213] [214] [212] [215] Warren Chan, Kyryl Zagorovsky, Mohamed Ahmed Abdou Mohamed, Co-Founder and CEO, Co-Founder and CTO, Resear …


Life Sciences Key Technologies

Problem: The electronics revolution has brought easy-to-use optical instrumentation, like plate readers and imaging systems, to laboratories. Since then, optical instrumentation for measurement and material characterization has become common place in s …


kardiolabsAI

Problem: Developing Artificial intelligence-based approach for automated reporting of CT Coronary Angiogram and computation of Fractional flow reserve from Coronary CT Angiography and Invasive Coronary Angiography in patient with coronary artery diseas …


ImmunoBiochem Corporation

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/Immunobiochem-Corp-Logo-v8-150×150.jpg ImmunoBiochem Corporation Description: [213] [214] [212] [215] Anton Neschadim, CEO, ceo@immunobiochem.com


Hypercare Inc.

https://h2i.utoronto.ca/wp-content/uploads/formidable/14/hypercare_horizontallogo-01-150×150.png Hypercare Inc. Albert Tai, Dr. Joseph Choi, Umar Azhar, CEO, COO, CTO, albert@hypercare.com, joe@hypercare.com, umar@hypercare.com


Honeybee

Problem: To develop health innovations and life-saving medicines, products are often tested on people for feasibility. During my master’s project, I ran a clinical trial and recruited young adults to test high protein pasta and paid $285/person. Due to …


Health-Bridge

https://h2i.utoronto.ca/wp-content/uploads/formidable/14/Logo-150×150.png Health-Bridge Haman, CEO, haman@health-bridge.ca


Enrich Bioscience, Inc.

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/EnrichBioscience_FinalLogo-1-150×150.png Enrich Bioscience, Inc. Description: [213] [214] [212] [215] Tarang Khare, Sun Chong Wang, Cofounder and CEO, Cofounder and Scientific Advisor, tar …


eHealth Access

Problem: 1- Medication Counselling and Patient Education: Patients with a low or an intermediate medication adherence had more than 2.5 folds greater odds of hospital readmission within 30 days of discharge. The lack of patient understanding of medicat …


Curovate

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/curovate_logo-150×150.png Curovate Description: [213] [214] [212] [215] Nirtal Shah, Co-founder, Physiotherapist, nirtal.shah@utoronto.ca


COSM Medical

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/COSM-logo-14-150×150.jpg COSM Medical Corp Derek Sham, MBA, Founder & CEO, dsham@cosm.care


Cohesys

https://h2i.utoronto.ca/wp-content/uploads/formidable/14/Cohesys-Logo-PDF.pdf Cohesys Dr. Michael Floros, Dr. Alex Lausch, Dr. Janaina Bortolatto, Michael Tessier, , https://www.linkedin.com/in/michael-floros/, https://www.linkedin.com/in/ajlausch/, htt …


Aditum Health

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/mychc_blue_logo-150×150.png Aditum Health Tamer Mikhael, Ron Van Holst, Frank Le, CEO, COO, CFO, tmikhail@aditumhealth.com, rvanholst@aditumhealth.com, fle@aditumhealth.com


16 Bit Inc.

https://h2i.utoronto.ca/wp-content/uploads/sites/6/formidable/14/16bit-logo-colour-150×150.png 16 Bit Inc. Description: [213] [214] [212] [215] Dr. Mark Cicero, Dr. Alexander Bilbily, Chief Operating Officer, Chief Executive Officer, mark@16bit.ai, alex …